Navigation Links
Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
Date:3/16/2009

using aspirin to prevent either strokes or heart disease in men under 45 or women under age 55 because heart attacks are less likely to occur in men younger than 45 and ischemic strokes are less likely to occur in women younger than 55, and because limited evidence exists in these age groups.

People age 80 and older could benefit more than younger people from aspirin because of their higher risk of cardiovascular disease, but the harms are also greater because the risk of gastrointestinal bleeding increases with age. The Task Force could not find clear evidence that the benefits of using aspirin outweigh the risks in people 80 years or older.

"The decision about whether the benefits of taking aspirin outweigh the harms is an individual one. Patients should work with their clinicians to look at their risk factors and decide if taking aspirin to lower their risk for heart attacks or strokes outweighs the potential risk of gastrointestinal bleeding," said Task Force Chair Ned Calonge, M.D., who is also chief medical officer and state epidemiologist for the Colorado Department of Public Health and Information.

Cardiovascular disease is the leading cause of death in the United States. It is the underlying or contributing cause in approximately 58 percent of all deaths. In 2003, 1 in every 3 adults had some type of cardiovascular disease. In adults over the age of 40, the risk of developing cardiovascular disease is 2 in 3 for men and more than 1 in 2 for women.

The Task Force could not find evidence about what the optimum dose of aspirin is to prevent heart attacks or strokes. Evidence shows benefits at a range of doses, and the risk of gastrointestinal bleeding may increase with the dose. A dose as low as 75 mg seems as effective as higher doses. Taking aspirin increases a person's chances of gastrointestinal bleeding, the sudden loss of blood or perforation of the digestive tract that can lead
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
2. Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer
3. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
4. Task Force Recommends Screening for Hearing Loss in All Newborns
5. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
6. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
7. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
8. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
9. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
10. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
11. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... 12, 2014 Sepsis is a life ... worldwide.  Education and awareness are fundamental to improving ... marks Sepsis Awareness Month and September 13 th ... Sepsis Alliance, "Sepsis, the body,s toxic reaction to ... every year, and thousands more are left with ...
(Date:9/11/2014)... , September 11, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/lqkmlx/radio_frequency ) has announced the ... Identification (RFID) Market in Healthcare (Tags, ... Industry Analysis, Size, Share, Growth, Trends ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
(Date:9/11/2014)... , Sept. 11, 2014 Array BioPharma Inc. ... focused on the discovery, development and commercialization of ... cancer, today announced the appointment of Victor ... Sandor will be responsible for leading clinical, medical ... portfolio, including binimetinib, a MEK inhibitor in Phase ...
Breaking Medicine Technology:Nanomix Supports Sepsis Awareness 2Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 2Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 3Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 2Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 3Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 4
(Date:9/14/2014)... Aliso Viejo, California (PRWEB) September 14, 2014 ... Pixel Film Studios, announces the production of the Flip ... X . , "Flip Flop is a simple-to-use and ... professional themed video with ease in Final Cut Pro ... "With 48 camera options and On-Screen controls, the user ...
(Date:9/14/2014)... is an internationally well-known designer and leader in the ... of cocktail dresses under $100 . To attract ... the company is also providing big savings for its ... black formal gowns and so on. The current discount ... company’s senior spokesman says, “We are pleased to announce ...
(Date:9/13/2014)... 2014 Over the past five ... in Australia have shown signs of struggle. ... confectionery goods has caused Australian consumers to turn ... to IBISWorld industry analyst Ryan Lin. This trend ... of health consciousness, which has alerted the Australian ...
(Date:9/13/2014)... Ticket Down is a dependable source for ... group that originally formed in 1994 in Los Angeles, California, ... group had been anticipating a new album since 2012 when ... about the release of their new album, they will be ... worldwide tour beginning in the United States in February. The ...
(Date:9/13/2014)... September 13, 2014 Healthcare employers, ... manufacturers turn to operators in the Healthcare ... manage risk. “Over the past five years, demand ... advances in the healthcare sector and the changing ... Phillips. Moreover, the 2010 Patient Protection and Affordable ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases Flip Flop Theme for Final Cut Pro X Users 2Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:Confectionery Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Confectionery Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 3Health News:Healthcare Consultants in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Healthcare Consultants in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... variant ups violence inclination, study finds , WEDNESDAY, June 17 (HealthDay ... for boys joining violent street gangs. But a new study finds ... part, in their genes. , Boys who have a variant of ... "warrior gene" -- are not only more likely to be in ...
... effective after heart attack and stroke , WEDNESDAY, June 17 ... the risk of stroke, heart attack and death in patients ... angina, a new trial shows. , Rivaroxaban is a pill ... In earlier studies, the drug was effective in preventing venous ...
... N.J., June 17 Nuvilex, Inc. (OTC Bulletin Board: ... that it has renewed its Master Distribution Agreement with ... and aesthetic solutions, for the distribution and sale of ... , The renewal is for one year and ...
... Sciences Category , , SUNNYVALE, Calif., June 17 ... ARAY ), a global leader in the field of radiosurgery, ... CEO, received the Ernst & Young Entrepreneur Of The Year(R) ... Northern California. According to Ernst & Young LLP, the ...
... , HERLEV, Denmark, June 17 A leading Danish cancer ... installing eight advanced radiotherapy treatment machines from Varian Medical Systems ... Herlev Hospital, to the north-west of Copenhagen, delivered ... patient using a Clinac(R) iX linear accelerator. , , ...
... Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced today ... Handok Pharmaceuticals Co., Ltd. ("Handok"), the largest diabetes ... Echo granted Handok rights to develop, market, sell ... painless, needle-free, transdermal, continuous glucose monitoring ("tCGM") in ...
Cached Medicine News:Health News:Boys May Feel a Genetic Pull Toward Gangs 2Health News:New Anticoagulant Pill Works Well in Trial 2Health News:New Anticoagulant Pill Works Well in Trial 3Health News:Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 2Health News:Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 3Health News:Accuray's Euan Thomson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Recipient in Northern California 2Health News:Accuray's Euan Thomson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Recipient in Northern California 3Health News:Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 2Health News:Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 3Health News:Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System 2Health News:Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System 3Health News:Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: